Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.
about
Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Adrenergic Signaling: A Target ...... the Antitumor Immune Response.
@en
Adrenergic Signaling: A Target ...... the Antitumor Immune Response.
@nl
type
label
Adrenergic Signaling: A Target ...... the Antitumor Immune Response.
@en
Adrenergic Signaling: A Target ...... the Antitumor Immune Response.
@nl
prefLabel
Adrenergic Signaling: A Target ...... the Antitumor Immune Response.
@en
Adrenergic Signaling: A Target ...... the Antitumor Immune Response.
@nl
P2093
P2860
P921
P356
P1476
Adrenergic Signaling: A Target ...... the Antitumor Immune Response.
@en
P2093
Bonnie L Hylander
Elizabeth A Repasky
Guanxi Qiao
Mark J Bucsek
Minhui Chen
P2860
P356
10.3389/FIMMU.2018.00164
P577
2018-02-06T00:00:00Z